Tilray Brands Current Ratio 2017-2025 | TLRY
Tilray Brands current ratio from 2017 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Tilray Brands Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-02-28 | $0.69B | $0.26B | 2.62 |
| 2024-11-30 | $0.71B | $0.28B | 2.54 |
| 2024-08-31 | $0.73B | $0.29B | 2.47 |
| 2024-05-31 | $0.68B | $0.30B | 2.27 |
| 2024-02-29 | $0.63B | $0.33B | 1.92 |
| 2023-11-30 | $0.64B | $0.40B | 1.63 |
| 2023-08-31 | $0.83B | $0.54B | 1.54 |
| 2023-05-31 | $0.77B | $0.43B | 1.79 |
| 2023-02-28 | $0.76B | $0.47B | 1.62 |
| 2022-11-30 | $0.82B | $0.43B | 1.91 |
| 2022-08-31 | $0.91B | $0.27B | 3.33 |
| 2022-05-31 | $0.80B | $0.28B | 2.87 |
| 2022-02-28 | $0.70B | $0.28B | 2.46 |
| 2021-11-30 | $0.71B | $0.32B | 2.25 |
| 2021-08-31 | $0.85B | $0.53B | 1.60 |
| 2021-05-31 | $0.88B | $0.40B | 2.20 |
| 2021-03-31 | $0.57B | $0.28B | 2.01 |
| 2021-02-28 | $0.00B | 0.00 | |
| 2020-12-31 | $0.00B | 0.00 | |
| 2020-11-30 | $0.00B | 0.00 | |
| 2020-09-30 | $0.31B | $0.13B | 2.28 |
| 2020-08-31 | $0.00B | 0.00 | |
| 2020-06-30 | $0.29B | $0.16B | 1.77 |
| 2020-03-31 | $0.34B | $0.17B | 1.98 |
| 2019-12-31 | $0.00B | 0.00 | |
| 2019-09-30 | $0.33B | $0.13B | 2.54 |
| 2019-06-30 | $0.36B | $0.18B | 2.04 |
| 2019-03-31 | $0.40B | $0.17B | 2.35 |
| 2018-12-31 | $0.55B | $0.03B | 21.37 |
| 2018-09-30 | $0.15B | $0.03B | 5.43 |
| 2018-06-30 | $0.04B | $0.06B | 0.62 |
| 2018-03-31 | $0.05B | $0.06B | 0.97 |
| 2018-02-28 | $0.00B | 0.00 | |
| 2017-12-31 | $0.01B | $0.05B | 0.25 |
| 2017-11-30 | $0.00B | 0.00 | |
| 2017-09-30 | $0.00B | 0.00 | |
| 2017-08-31 | $0.00B | 0.00 | |
| 2017-06-30 | $0.00B | 0.00 | |
| 2017-05-31 | $0.00B | 0.00 | |
| 2017-03-31 | $0.00B | 0.00 | |
| 2017-02-28 | $0.01B | $0.02B | 0.55 |
| 2016-11-30 | $0.01B | $0.02B | 0.55 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.488B | $0.789B |
| Tilray Brands Inc. is a cannabis-lifestyle and consumer packaged goods company. It operates principally in Canada, the United States, Europe, Australia and Latin America. Tilray Brands Inc., formerly known as Tilray Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.763B | 27.35 |
| Boston Scientific (BSX) | United States | $152.152B | 38.10 |
| Stryker (SYK) | United States | $142.721B | 30.67 |
| EssilorLuxottica (ESLOY) | France | $133.556B | 0.00 |
| Medtronic (MDT) | Ireland | $108.708B | 15.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.613B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.796B | 26.03 |
| ResMed (RMD) | United States | $34.691B | 26.06 |
| GE HealthCare Technologies (GEHC) | United States | $32.200B | 15.29 |
| Agilent Technologies (A) | United States | $30.677B | 20.26 |
| Terumo (TRUMY) | Japan | $28.397B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.827B | 17.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.388B | 12.88 |
| Insulet (PODD) | United States | $17.717B | 75.76 |
| Baxter (BAX) | United States | $15.988B | 11.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.272B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Demant (WILYY) | Denmark | $7.600B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.145B | 17.57 |
| Bio-Rad Laboratories (BIO) | United States | $6.837B | 23.67 |
| Prestige Consumer Healthcare (PBH) | United States | $4.024B | 19.20 |
| Perrigo (PRGO) | Ireland | $3.510B | 10.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.362B | 28.64 |
| Haemonetics (HAE) | United States | $3.166B | 14.90 |
| Envista Holdings (NVST) | United States | $2.725B | 22.03 |
| GN Store Nord (GNNDY) | Denmark | $2.260B | 18.72 |
| LeMaitre Vascular (LMAT) | United States | $2.050B | 46.77 |
| QuidelOrtho (QDEL) | United States | $1.875B | 15.70 |
| AtriCure (ATRC) | United States | $1.480B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.401B | 22.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.235B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.148B | 11.05 |
| BioLife Solutions (BLFS) | United States | $1.145B | 0.00 |
| Neogen (NEOG) | United States | $1.096B | 14.03 |
| InMode (INMD) | Israel | $0.981B | 8.98 |
| Phibro Animal Health (PAHC) | United States | $0.754B | 11.56 |
| Evolus (EOLS) | United States | $0.735B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.713B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.580B | 0.00 |
| CeriBell (CBLL) | United States | $0.577B | 0.00 |
| Owens & Minor (OMI) | United States | $0.545B | 4.64 |
| Valneva SE (VALN) | France | $0.531B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.514B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.479B | 0.00 |
| Omeros (OMER) | United States | $0.427B | 0.00 |
| Surmodics (SRDX) | United States | $0.400B | 0.00 |
| SNDL (SNDL) | Canada | $0.392B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.357B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.343B | 14.86 |
| Verano Holdings (VRNOF) | United States | $0.323B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.284B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.279B | 25.25 |
| Aurora Cannabis (ACB) | Canada | $0.261B | 46.40 |
| Canopy Growth (CGC) | Canada | $0.254B | 0.00 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| ZimVie (ZIMV) | United States | $0.252B | 15.10 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.231B | 0.00 |
| Quanterix (QTRX) | United States | $0.223B | 0.00 |
| High Tide (HITI) | Canada | $0.195B | 0.00 |
| Biote (BTMD) | United States | $0.182B | 4.16 |
| Utah Medical Products (UTMD) | United States | $0.170B | 13.69 |
| TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 51.00 |
| Organigram Global (OGI) | Canada | $0.146B | 0.00 |
| Jin Medical (ZJYL) | China | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.142B | 17.46 |
| TerrAscend (TSNDF) | Canada | $0.128B | 0.00 |
| Agape ATP (ATPC) | $0.115B | 0.00 | |
| Exagen (XGN) | United States | $0.112B | 0.00 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.082B | 0.00 |
| Veru (VERU) | United States | $0.079B | 0.00 |
| Fonar (FONR) | United States | $0.078B | 10.91 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| United Health Products (UEEC) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| Apyx Medical (APYX) | United States | $0.039B | 0.00 |
| Safety Shot (SHOT) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 54.00 |
| United-Guardian (UG) | United States | $0.036B | 11.14 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |